

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | diol metabolic process (GO:0034311) | 9.66653311 |
| 2 | sphingoid metabolic process (GO:0046519) | 8.44183374 |
| 3 | DNA deamination (GO:0045006) | 7.53200474 |
| 4 | DNA methylation involved in gamete generation (GO:0043046) | 7.42611606 |
| 5 | protein-chromophore linkage (GO:0018298) | 6.79657531 |
| 6 | regulation of odontogenesis of dentin-containing tooth (GO:0042487) | 6.50908733 |
| 7 | regulation of meiosis I (GO:0060631) | 6.22002728 |
| 8 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 5.64573310 |
| 9 | cell migration involved in heart development (GO:0060973) | 5.53305085 |
| 10 | lipopolysaccharide biosynthetic process (GO:0009103) | 5.49542107 |
| 11 | piRNA metabolic process (GO:0034587) | 5.42433537 |
| 12 | cellular anion homeostasis (GO:0030002) | 5.40952598 |
| 13 | somite rostral/caudal axis specification (GO:0032525) | 5.09167211 |
| 14 | sulfate transmembrane transport (GO:1902358) | 5.08656924 |
| 15 | regulation of Wnt signaling pathway involved in heart development (GO:0003307) | 5.05258641 |
| 16 | regulation of mesoderm development (GO:2000380) | 4.99677434 |
| 17 | heart field specification (GO:0003128) | 4.92864226 |
| 18 | secondary heart field specification (GO:0003139) | 4.92864226 |
| 19 | regulation of protein glycosylation (GO:0060049) | 4.82799574 |
| 20 | epithelial to mesenchymal transition involved in endocardial cushion formation (GO:0003198) | 4.80289087 |
| 21 | lipopolysaccharide metabolic process (GO:0008653) | 4.65695917 |
| 22 | negative regulation of G2/M transition of mitotic cell cycle (GO:0010972) | 4.49285758 |
| 23 | heme transport (GO:0015886) | 4.36913025 |
| 24 | regulation of pigment cell differentiation (GO:0050932) | 4.32180541 |
| 25 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 4.30898218 |
| 26 | sulfate transport (GO:0008272) | 4.30443826 |
| 27 | positive regulation of developmental pigmentation (GO:0048087) | 4.29433243 |
| 28 | positive regulation of meiosis (GO:0045836) | 4.24605626 |
| 29 | regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072307) | 4.19283717 |
| 30 | L-phenylalanine catabolic process (GO:0006559) | 4.08704488 |
| 31 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.08704488 |
| 32 | negative regulation of cell fate commitment (GO:0010454) | 4.06786748 |
| 33 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 4.03131941 |
| 34 | positive regulation of meiotic cell cycle (GO:0051446) | 4.00108752 |
| 35 | cytidine metabolic process (GO:0046087) | 3.97160644 |
| 36 | cytidine catabolic process (GO:0006216) | 3.97160644 |
| 37 | cytidine deamination (GO:0009972) | 3.97160644 |
| 38 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 3.95301798 |
| 39 | positive regulation of cell fate commitment (GO:0010455) | 3.93697385 |
| 40 | negative regulation of cell fate specification (GO:0009996) | 3.92499009 |
| 41 | serotonin receptor signaling pathway (GO:0007210) | 3.88684541 |
| 42 | behavioral response to nicotine (GO:0035095) | 3.88175069 |
| 43 | tyrosine metabolic process (GO:0006570) | 3.86223689 |
| 44 | paraxial mesoderm development (GO:0048339) | 3.83289029 |
| 45 | positive regulation of fibroblast migration (GO:0010763) | 3.81599652 |
| 46 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 3.79039764 |
| 47 | toxin metabolic process (GO:0009404) | 3.75311669 |
| 48 | cardiac ventricle formation (GO:0003211) | 3.71124309 |
| 49 | negative regulation of stem cell proliferation (GO:2000647) | 3.69947763 |
| 50 | adaptation of signaling pathway (GO:0023058) | 3.67623339 |
| 51 | SMAD protein complex assembly (GO:0007183) | 3.65181433 |
| 52 | negative regulation of cell cycle G2/M phase transition (GO:1902750) | 3.63158179 |
| 53 | necroptotic process (GO:0070266) | 3.52524227 |
| 54 | tachykinin receptor signaling pathway (GO:0007217) | 3.48129620 |
| 55 | L-phenylalanine metabolic process (GO:0006558) | 3.45490310 |
| 56 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.45490310 |
| 57 | positive regulation of defense response to virus by host (GO:0002230) | 3.41946157 |
| 58 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 3.40378821 |
| 59 | aromatic amino acid family catabolic process (GO:0009074) | 3.39217724 |
| 60 | negative regulation of systemic arterial blood pressure (GO:0003085) | 3.37208825 |
| 61 | cardiac chamber formation (GO:0003207) | 3.36376426 |
| 62 | ribonucleoprotein complex disassembly (GO:0032988) | 3.35032645 |
| 63 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.33356757 |
| 64 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.33356757 |
| 65 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.31649425 |
| 66 | cell migration involved in gastrulation (GO:0042074) | 3.28371498 |
| 67 | regulation of odontogenesis (GO:0042481) | 3.22909572 |
| 68 | intracellular pH reduction (GO:0051452) | 3.21422741 |
| 69 | endothelial cell differentiation (GO:0045446) | 3.19113148 |
| 70 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 3.18674535 |
| 71 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.18256608 |
| 72 | indolalkylamine metabolic process (GO:0006586) | 3.18225474 |
| 73 | specification of organ identity (GO:0010092) | 3.11718049 |
| 74 | centriole replication (GO:0007099) | 3.05560631 |
| 75 | aromatic amino acid family metabolic process (GO:0009072) | 3.05214176 |
| 76 | negative regulation of glycoprotein metabolic process (GO:1903019) | 3.03524177 |
| 77 | sleep (GO:0030431) | 3.03483255 |
| 78 | negative regulation of telomere maintenance (GO:0032205) | 3.00117691 |
| 79 | regulation of gonadotropin secretion (GO:0032276) | 2.99936170 |
| 80 | signal transduction involved in regulation of gene expression (GO:0023019) | 2.99459578 |
| 81 | glycerol metabolic process (GO:0006071) | 2.99381007 |
| 82 | primary amino compound metabolic process (GO:1901160) | 2.97725707 |
| 83 | regulation of SMAD protein import into nucleus (GO:0060390) | 2.97535320 |
| 84 | iron coordination entity transport (GO:1901678) | 2.96248115 |
| 85 | flavonoid metabolic process (GO:0009812) | 2.96054600 |
| 86 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 2.95099522 |
| 87 | postsynaptic membrane organization (GO:0001941) | 2.91987603 |
| 88 | positive regulation of interleukin-17 production (GO:0032740) | 2.91660893 |
| 89 | notochord development (GO:0030903) | 2.91195997 |
| 90 | negative regulation of cell-matrix adhesion (GO:0001953) | 2.90950482 |
| 91 | rhodopsin mediated signaling pathway (GO:0016056) | 2.90077677 |
| 92 | regulation of interleukin-5 production (GO:0032674) | 2.84178870 |
| 93 | urate metabolic process (GO:0046415) | 2.83411694 |
| 94 | cellular response to gamma radiation (GO:0071480) | 2.83179806 |
| 95 | positive regulation of SMAD protein import into nucleus (GO:0060391) | 2.82029375 |
| 96 | heart valve formation (GO:0003188) | 2.81621657 |
| 97 | sulfation (GO:0051923) | 2.79620669 |
| 98 | growth hormone receptor signaling pathway (GO:0060396) | 2.78737597 |
| 99 | sulfur compound transport (GO:0072348) | 2.78735009 |
| 100 | sphingosine metabolic process (GO:0006670) | 10.6191244 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | AR_21572438_ChIP-Seq_LNCaP_Human | 3.25585755 |
| 2 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 3.24494328 |
| 3 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.87472044 |
| 4 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.85891357 |
| 5 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.74649912 |
| 6 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.61169610 |
| 7 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.51284783 |
| 8 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.33384252 |
| 9 | VDR_22108803_ChIP-Seq_LS180_Human | 2.27095348 |
| 10 | P300_19829295_ChIP-Seq_ESCs_Human | 2.19583239 |
| 11 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.13830592 |
| 12 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 2.03181033 |
| 13 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.99616451 |
| 14 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.96831235 |
| 15 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.89017173 |
| 16 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.86310043 |
| 17 | HOXB7_26014856_ChIP-Seq_BT474_Human | 1.86276149 |
| 18 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.79901297 |
| 19 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.78853845 |
| 20 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.78853845 |
| 21 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.77564988 |
| 22 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.75299578 |
| 23 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.74334286 |
| 24 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.71994183 |
| 25 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.68627646 |
| 26 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.66898416 |
| 27 | OCT4_20526341_ChIP-Seq_ESCs_Human | 1.64374178 |
| 28 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.64320168 |
| 29 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 1.60234238 |
| 30 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 1.54643578 |
| 31 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.54499086 |
| 32 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.54235043 |
| 33 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.46863777 |
| 34 | NCOR_22424771_ChIP-Seq_293T_Human | 1.45702925 |
| 35 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.44192807 |
| 36 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.43818571 |
| 37 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.43327483 |
| 38 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.43302152 |
| 39 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.42607463 |
| 40 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.40324167 |
| 41 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.35473750 |
| 42 | STAT3_23295773_ChIP-Seq_U87_Human | 1.34393006 |
| 43 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.34150282 |
| 44 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.32202055 |
| 45 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 1.29872805 |
| 46 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.29752088 |
| 47 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.29469025 |
| 48 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.28733191 |
| 49 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.27035859 |
| 50 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.26560224 |
| 51 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.26263462 |
| 52 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.25531838 |
| 53 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.25405760 |
| 54 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.25301665 |
| 55 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.23945146 |
| 56 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.23820030 |
| 57 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.23720875 |
| 58 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.23720875 |
| 59 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.23114594 |
| 60 | TCF4_23295773_ChIP-Seq_U87_Human | 1.22751818 |
| 61 | FUS_26573619_Chip-Seq_HEK293_Human | 1.22612492 |
| 62 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 1.22350154 |
| 63 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.22280042 |
| 64 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 1.21796169 |
| 65 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.20843487 |
| 66 | AR_25329375_ChIP-Seq_VCAP_Human | 1.20668911 |
| 67 | P53_21459846_ChIP-Seq_SAOS-2_Human | 1.19904297 |
| 68 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.17931901 |
| 69 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.16562999 |
| 70 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.16178806 |
| 71 | GATA3_21867929_ChIP-Seq_TH1_Mouse | 1.13346850 |
| 72 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 1.13334361 |
| 73 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.12344093 |
| 74 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.11971053 |
| 75 | CEBPB_22108803_ChIP-Seq_LS180_Human | 1.10917716 |
| 76 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.10116384 |
| 77 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.09834197 |
| 78 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.08308905 |
| 79 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.08239009 |
| 80 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.08203952 |
| 81 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.07887345 |
| 82 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.07321984 |
| 83 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.07191290 |
| 84 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.07191290 |
| 85 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.05676112 |
| 86 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.05447576 |
| 87 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.04994260 |
| 88 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.04638144 |
| 89 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.04444940 |
| 90 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.03508700 |
| 91 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.03061863 |
| 92 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.02569514 |
| 93 | RAC3_21632823_ChIP-Seq_H3396_Human | 1.02173423 |
| 94 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.00504542 |
| 95 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.99962837 |
| 96 | GATA3_26560356_Chip-Seq_TH1_Human | 0.99587134 |
| 97 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.97111947 |
| 98 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.96927953 |
| 99 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.96248215 |
| 100 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.95480322 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 7.97473550 |
| 2 | MP0003136_yellow_coat_color | 6.50377224 |
| 3 | MP0005171_absent_coat_pigmentation | 6.17114911 |
| 4 | MP0003646_muscle_fatigue | 4.90189731 |
| 5 | MP0002653_abnormal_ependyma_morphology | 4.12521376 |
| 6 | MP0003045_fibrosis | 3.73130703 |
| 7 | MP0003890_abnormal_embryonic-extraembry | 3.43926608 |
| 8 | MP0002234_abnormal_pharynx_morphology | 3.41603396 |
| 9 | MP0005670_abnormal_white_adipose | 3.27857920 |
| 10 | MP0005360_urolithiasis | 3.05490098 |
| 11 | MP0003879_abnormal_hair_cell | 3.02499817 |
| 12 | MP0000569_abnormal_digit_pigmentation | 2.67808659 |
| 13 | MP0004381_abnormal_hair_follicle | 2.63732334 |
| 14 | MP0002938_white_spotting | 2.41861461 |
| 15 | MP0005085_abnormal_gallbladder_physiolo | 2.21613606 |
| 16 | MP0002138_abnormal_hepatobiliary_system | 2.07598682 |
| 17 | MP0004147_increased_porphyrin_level | 1.99651667 |
| 18 | MP0002095_abnormal_skin_pigmentation | 1.78898788 |
| 19 | MP0005075_abnormal_melanosome_morpholog | 1.63013631 |
| 20 | MP0000749_muscle_degeneration | 1.50236459 |
| 21 | MP0005646_abnormal_pituitary_gland | 1.48539377 |
| 22 | MP0001873_stomach_inflammation | 1.47027549 |
| 23 | MP0003195_calcinosis | 1.43800700 |
| 24 | MP0004130_abnormal_muscle_cell | 1.39860986 |
| 25 | MP0002160_abnormal_reproductive_system | 1.36576097 |
| 26 | MP0003705_abnormal_hypodermis_morpholog | 1.34177229 |
| 27 | MP0003950_abnormal_plasma_membrane | 1.31539995 |
| 28 | MP0008875_abnormal_xenobiotic_pharmacok | 1.30421304 |
| 29 | MP0006292_abnormal_olfactory_placode | 1.28412370 |
| 30 | MP0002168_other_aberrant_phenotype | 1.28264162 |
| 31 | MP0002735_abnormal_chemical_nociception | 1.27677316 |
| 32 | MP0004885_abnormal_endolymph | 1.16755509 |
| 33 | MP0005410_abnormal_fertilization | 1.12556323 |
| 34 | MP0008872_abnormal_physiological_respon | 1.10666768 |
| 35 | MP0003878_abnormal_ear_physiology | 1.08026954 |
| 36 | MP0005377_hearing/vestibular/ear_phenot | 1.08026954 |
| 37 | MP0005365_abnormal_bile_salt | 1.07762817 |
| 38 | MP0005174_abnormal_tail_pigmentation | 1.06730115 |
| 39 | MP0001486_abnormal_startle_reflex | 1.00640657 |
| 40 | MP0001501_abnormal_sleep_pattern | 0.97681840 |
| 41 | MP0002075_abnormal_coat/hair_pigmentati | 0.97050066 |
| 42 | MP0003137_abnormal_impulse_conducting | 0.95717905 |
| 43 | MP0005551_abnormal_eye_electrophysiolog | 0.94877012 |
| 44 | MP0001968_abnormal_touch/_nociception | 0.94410153 |
| 45 | MP0001661_extended_life_span | 0.84185599 |
| 46 | MP0005389_reproductive_system_phenotype | 0.84111340 |
| 47 | MP0004043_abnormal_pH_regulation | 0.83990104 |
| 48 | MP0002876_abnormal_thyroid_physiology | 0.83548521 |
| 49 | MP0009745_abnormal_behavioral_response | 0.83205194 |
| 50 | MP0005395_other_phenotype | 0.81141435 |
| 51 | MP0002272_abnormal_nervous_system | 0.80674765 |
| 52 | MP0009046_muscle_twitch | 0.79165550 |
| 53 | MP0001186_pigmentation_phenotype | 0.77654149 |
| 54 | MP0002102_abnormal_ear_morphology | 0.76063449 |
| 55 | MP0003252_abnormal_bile_duct | 0.75975673 |
| 56 | MP0002736_abnormal_nociception_after | 0.73192467 |
| 57 | MP0001970_abnormal_pain_threshold | 0.68817622 |
| 58 | MP0004145_abnormal_muscle_electrophysio | 0.66674892 |
| 59 | MP0000015_abnormal_ear_pigmentation | 0.65031543 |
| 60 | MP0004142_abnormal_muscle_tone | 0.64168590 |
| 61 | MP0001984_abnormal_olfaction | 0.63188138 |
| 62 | MP0009764_decreased_sensitivity_to | 0.62376697 |
| 63 | MP0002733_abnormal_thermal_nociception | 0.61794116 |
| 64 | MP0005319_abnormal_enzyme/_coenzyme | 0.61712177 |
| 65 | MP0000026_abnormal_inner_ear | 0.58907794 |
| 66 | MP0002163_abnormal_gland_morphology | 0.58186374 |
| 67 | MP0005666_abnormal_adipose_tissue | 0.56852779 |
| 68 | MP0001764_abnormal_homeostasis | 0.56151523 |
| 69 | MP0000372_irregular_coat_pigmentation | 0.54495171 |
| 70 | MP0005330_cardiomyopathy | 0.53689382 |
| 71 | MP0005253_abnormal_eye_physiology | 0.53650849 |
| 72 | MP0000427_abnormal_hair_cycle | 0.53283793 |
| 73 | MP0002909_abnormal_adrenal_gland | 0.52600690 |
| 74 | MP0008877_abnormal_DNA_methylation | 0.51882223 |
| 75 | MP0001986_abnormal_taste_sensitivity | 0.51061055 |
| 76 | MP0003698_abnormal_male_reproductive | 0.50489068 |
| 77 | MP0002064_seizures | 0.49296130 |
| 78 | MP0002254_reproductive_system_inflammat | 0.48716929 |
| 79 | MP0010352_gastrointestinal_tract_polyps | 0.48435260 |
| 80 | MP0002572_abnormal_emotion/affect_behav | 0.47688193 |
| 81 | MP0009115_abnormal_fat_cell | 0.46969263 |
| 82 | MP0002332_abnormal_exercise_endurance | 0.46331668 |
| 83 | MP0008770_decreased_survivor_rate | 0.46130929 |
| 84 | MP0003937_abnormal_limbs/digits/tail_de | 0.45588199 |
| 85 | MP0002751_abnormal_autonomic_nervous | 0.45386339 |
| 86 | MP0008569_lethality_at_weaning | 0.43270223 |
| 87 | MP0002269_muscular_atrophy | 0.42986147 |
| 88 | MP0001800_abnormal_humoral_immune | 0.42842722 |
| 89 | MP0001790_abnormal_immune_system | 0.42627570 |
| 90 | MP0005387_immune_system_phenotype | 0.42627570 |
| 91 | MP0002210_abnormal_sex_determination | 0.42470931 |
| 92 | MP0001324_abnormal_eye_pigmentation | 0.41456629 |
| 93 | MP0004233_abnormal_muscle_weight | 0.41349274 |
| 94 | MP0002277_abnormal_respiratory_mucosa | 0.40495205 |
| 95 | MP0001905_abnormal_dopamine_level | 0.39938986 |
| 96 | MP0005647_abnormal_sex_gland | 0.39879359 |
| 97 | MP0003635_abnormal_synaptic_transmissio | 0.39645941 |
| 98 | MP0005334_abnormal_fat_pad | 0.39280525 |
| 99 | MP0005332_abnormal_amino_acid | 0.38937591 |
| 100 | MP0000470_abnormal_stomach_morphology | 0.38410495 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Autoimmune hemolytic anemia (HP:0001890) | 6.73617945 |
| 2 | Focal motor seizures (HP:0011153) | 6.44942601 |
| 3 | Amelogenesis imperfecta (HP:0000705) | 6.18976434 |
| 4 | Autoimmune thrombocytopenia (HP:0001973) | 6.18295828 |
| 5 | Birth length less than 3rd percentile (HP:0003561) | 5.73325017 |
| 6 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 5.49864786 |
| 7 | Parakeratosis (HP:0001036) | 5.18829202 |
| 8 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.68905608 |
| 9 | Increased IgM level (HP:0003496) | 4.35662594 |
| 10 | Acanthocytosis (HP:0001927) | 4.23113730 |
| 11 | Spontaneous hematomas (HP:0007420) | 3.99354172 |
| 12 | Aplastic anemia (HP:0001915) | 3.50146413 |
| 13 | Colon cancer (HP:0003003) | 3.49295988 |
| 14 | Dialeptic seizures (HP:0011146) | 3.33138710 |
| 15 | Pendular nystagmus (HP:0012043) | 3.31669938 |
| 16 | Congenital ichthyosiform erythroderma (HP:0007431) | 3.21443899 |
| 17 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 3.20135578 |
| 18 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.16943586 |
| 19 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.16943586 |
| 20 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.14761163 |
| 21 | Pancreatic cysts (HP:0001737) | 2.99245874 |
| 22 | Enlarged epiphyses (HP:0010580) | 2.96921482 |
| 23 | Neonatal hypoglycemia (HP:0001998) | 2.94939469 |
| 24 | Conjunctival telangiectasia (HP:0000524) | 2.94210259 |
| 25 | Lip pit (HP:0100267) | 2.89048038 |
| 26 | Hypochromic anemia (HP:0001931) | 2.77271970 |
| 27 | Congenital stationary night blindness (HP:0007642) | 2.73971147 |
| 28 | Abnormality of alanine metabolism (HP:0010916) | 2.73338427 |
| 29 | Hyperalaninemia (HP:0003348) | 2.73338427 |
| 30 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.73338427 |
| 31 | Proximal amyotrophy (HP:0007126) | 2.73258786 |
| 32 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.70991465 |
| 33 | Abnormality of the fingertips (HP:0001211) | 2.69669101 |
| 34 | Hematochezia (HP:0002573) | 2.66727256 |
| 35 | Rectal prolapse (HP:0002035) | 2.65601884 |
| 36 | Esophageal varix (HP:0002040) | 2.61138686 |
| 37 | Focal seizures (HP:0007359) | 2.60872130 |
| 38 | Potter facies (HP:0002009) | 2.60427090 |
| 39 | Facial shape deformation (HP:0011334) | 2.60427090 |
| 40 | Congenital sensorineural hearing impairment (HP:0008527) | 2.58729235 |
| 41 | Abnormality of T cell physiology (HP:0011840) | 2.55423670 |
| 42 | Anterior segment dysgenesis (HP:0007700) | 2.52655953 |
| 43 | Constricted visual fields (HP:0001133) | 2.52415834 |
| 44 | Chin dimple (HP:0010751) | 2.51367563 |
| 45 | Eosinophilia (HP:0001880) | 2.43454544 |
| 46 | Abnormality of T cell number (HP:0011839) | 2.40281473 |
| 47 | Erythroderma (HP:0001019) | 2.33615844 |
| 48 | Enlarged kidneys (HP:0000105) | 2.31378846 |
| 49 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.31085169 |
| 50 | Glucose intolerance (HP:0000833) | 2.30796923 |
| 51 | Myotonia (HP:0002486) | 2.30039674 |
| 52 | Synostosis of carpal bones (HP:0005048) | 2.28423386 |
| 53 | Cerebellar dysplasia (HP:0007033) | 2.24824168 |
| 54 | Abnormality of the renal cortex (HP:0011035) | 2.24557466 |
| 55 | Hypoalbuminemia (HP:0003073) | 2.20544064 |
| 56 | Abnormal albumin level (HP:0012116) | 2.20544064 |
| 57 | Difficulty walking (HP:0002355) | 2.15433980 |
| 58 | Vertebral arch anomaly (HP:0008438) | 2.15112471 |
| 59 | Depressed nasal tip (HP:0000437) | 2.11631931 |
| 60 | Severe visual impairment (HP:0001141) | 2.09739016 |
| 61 | Type II lissencephaly (HP:0007260) | 2.08289839 |
| 62 | Poikilocytosis (HP:0004447) | 2.06049813 |
| 63 | Radial bowing (HP:0002986) | 2.02928486 |
| 64 | Abnormality of the renal medulla (HP:0100957) | 2.01658147 |
| 65 | Dehydration (HP:0001944) | 1.99731978 |
| 66 | Opisthotonus (HP:0002179) | 1.95123824 |
| 67 | Hypokalemia (HP:0002900) | 1.94131649 |
| 68 | Hyperglycemia (HP:0003074) | 1.94043592 |
| 69 | Progressive inability to walk (HP:0002505) | 1.90790274 |
| 70 | Broad ribs (HP:0000885) | 1.87356489 |
| 71 | Granulocytopenia (HP:0001913) | 1.86571271 |
| 72 | Decreased circulating renin level (HP:0003351) | 1.85363584 |
| 73 | Inability to walk (HP:0002540) | 1.84959229 |
| 74 | Abnormality of macular pigmentation (HP:0008002) | 1.84443504 |
| 75 | Nephronophthisis (HP:0000090) | 1.83327003 |
| 76 | Sparse lateral eyebrow (HP:0005338) | 1.83001300 |
| 77 | Non-midline cleft lip (HP:0100335) | 1.82861365 |
| 78 | Agammaglobulinemia (HP:0004432) | 1.81443288 |
| 79 | Pancreatic fibrosis (HP:0100732) | 1.79247662 |
| 80 | Renal tubular acidosis (HP:0001947) | 1.79234433 |
| 81 | Scapular winging (HP:0003691) | 1.78588887 |
| 82 | Epileptic encephalopathy (HP:0200134) | 1.78355763 |
| 83 | Abnormal drinking behavior (HP:0030082) | 1.77136638 |
| 84 | Polydipsia (HP:0001959) | 1.77136638 |
| 85 | Abnormality of eosinophils (HP:0001879) | 1.76816819 |
| 86 | Abnormality of the renal collecting system (HP:0004742) | 1.75816628 |
| 87 | Hypoplastic iliac wings (HP:0002866) | 1.73993056 |
| 88 | Portal hypertension (HP:0001409) | 1.72796131 |
| 89 | Duplicated collecting system (HP:0000081) | 1.71842124 |
| 90 | Neutropenia (HP:0001875) | 1.69892142 |
| 91 | Cavernous hemangioma (HP:0001048) | 1.65948753 |
| 92 | Coarctation of aorta (HP:0001680) | 1.65582339 |
| 93 | Generalized aminoaciduria (HP:0002909) | 1.65435951 |
| 94 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.64110684 |
| 95 | Gaze-evoked nystagmus (HP:0000640) | 1.63595019 |
| 96 | Conjugated hyperbilirubinemia (HP:0002908) | 1.60362648 |
| 97 | Lipid accumulation in hepatocytes (HP:0006561) | 1.59682256 |
| 98 | Abnormal glucose tolerance (HP:0001952) | 1.58798197 |
| 99 | Gangrene (HP:0100758) | 1.58760121 |
| 100 | Abnormality of T cells (HP:0002843) | 1.56815351 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | LATS1 | 8.22975302 |
| 2 | STK38L | 5.90407615 |
| 3 | LATS2 | 5.08219628 |
| 4 | TLK1 | 4.87891275 |
| 5 | PIK3CA | 3.34177905 |
| 6 | FRK | 2.74808697 |
| 7 | CDK19 | 2.63571209 |
| 8 | ZAK | 2.47610737 |
| 9 | NLK | 2.39429989 |
| 10 | ACVR1B | 2.34903344 |
| 11 | PRKD3 | 2.12729723 |
| 12 | ADRBK2 | 2.11891392 |
| 13 | MAP2K2 | 2.11701509 |
| 14 | STK38 | 2.04020284 |
| 15 | BMPR1B | 1.97239171 |
| 16 | GRK7 | 1.76460392 |
| 17 | STK3 | 1.68325714 |
| 18 | MELK | 1.36040985 |
| 19 | OXSR1 | 1.36025196 |
| 20 | ADRBK1 | 1.31160816 |
| 21 | TAF1 | 1.23162055 |
| 22 | GRK5 | 1.20002235 |
| 23 | CSNK1A1L | 1.10377726 |
| 24 | STK10 | 1.06766879 |
| 25 | TGFBR2 | 1.04502505 |
| 26 | WNK4 | 1.03084252 |
| 27 | NEK1 | 0.99326430 |
| 28 | MOS | 0.94469788 |
| 29 | TGFBR1 | 0.87701708 |
| 30 | WNK3 | 0.84992062 |
| 31 | STK11 | 0.81287031 |
| 32 | MAP2K3 | 0.76171025 |
| 33 | PRKCG | 0.76000432 |
| 34 | PIK3CG | 0.74517292 |
| 35 | PRKAA2 | 0.73232935 |
| 36 | EIF2AK3 | 0.72734623 |
| 37 | PDPK1 | 0.72458689 |
| 38 | MAP2K6 | 0.72100136 |
| 39 | KIT | 0.69838796 |
| 40 | RET | 0.69213517 |
| 41 | ERN1 | 0.66973797 |
| 42 | MAP4K2 | 0.64069481 |
| 43 | TXK | 0.63473719 |
| 44 | PRKD1 | 0.60808753 |
| 45 | DAPK2 | 0.54349739 |
| 46 | BMPR2 | 0.54038360 |
| 47 | MAPK12 | 0.53696038 |
| 48 | PINK1 | 0.48534549 |
| 49 | NEK2 | 0.47652132 |
| 50 | STK39 | 0.47144104 |
| 51 | GRK1 | 0.46118736 |
| 52 | MAP2K1 | 0.45612138 |
| 53 | TAOK3 | 0.41104244 |
| 54 | MAP3K2 | 0.38955605 |
| 55 | INSRR | 0.37633063 |
| 56 | CSNK1D | 0.37001311 |
| 57 | CSNK1G3 | 0.35999043 |
| 58 | IKBKB | 0.34916644 |
| 59 | IRAK3 | 0.34310086 |
| 60 | CAMK1D | 0.33424504 |
| 61 | PDGFRB | 0.32575704 |
| 62 | PLK4 | 0.32473748 |
| 63 | CAMK2A | 0.32469708 |
| 64 | TNK2 | 0.31541475 |
| 65 | DYRK2 | 0.30811314 |
| 66 | CSNK1G2 | 0.29130176 |
| 67 | EIF2AK2 | 0.27714096 |
| 68 | CAMKK2 | 0.27464393 |
| 69 | PLK2 | 0.26482379 |
| 70 | PRKACA | 0.25446154 |
| 71 | MARK3 | 0.24381070 |
| 72 | CSNK1G1 | 0.24371545 |
| 73 | JAK3 | 0.23789862 |
| 74 | CSNK1A1 | 0.23542459 |
| 75 | NEK9 | 0.21748182 |
| 76 | PRKCI | 0.20587883 |
| 77 | CHEK2 | 0.18967532 |
| 78 | PHKG2 | 0.18515590 |
| 79 | PHKG1 | 0.18515590 |
| 80 | PIM1 | 0.17666251 |
| 81 | PRKG1 | 0.16600528 |
| 82 | PTK2 | 0.16432193 |
| 83 | SYK | 0.14828550 |
| 84 | PLK1 | 0.13457719 |
| 85 | GRK6 | 0.12958705 |
| 86 | CSNK2A1 | 0.11697549 |
| 87 | PRKCE | 0.11136213 |
| 88 | ABL1 | 0.10985381 |
| 89 | MAP3K8 | 0.10900235 |
| 90 | AKT2 | 0.10659994 |
| 91 | TIE1 | 0.10261756 |
| 92 | PAK1 | 0.10008323 |
| 93 | CCNB1 | 0.09512990 |
| 94 | AURKA | 0.09141360 |
| 95 | OBSCN | 0.09094520 |
| 96 | JAK2 | 0.08623068 |
| 97 | CSNK2A2 | 0.08517560 |
| 98 | TEC | 0.07769800 |
| 99 | MAPKAPK5 | 0.07765874 |
| 100 | PRKCA | 0.07004225 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 5.68129714 |
| 2 | Phototransduction_Homo sapiens_hsa04744 | 3.85660440 |
| 3 | Nicotine addiction_Homo sapiens_hsa05033 | 3.14193713 |
| 4 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 2.93290883 |
| 5 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.88167038 |
| 6 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 2.63113831 |
| 7 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.60197057 |
| 8 | African trypanosomiasis_Homo sapiens_hsa05143 | 2.43645230 |
| 9 | Taste transduction_Homo sapiens_hsa04742 | 2.24584579 |
| 10 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 2.21677074 |
| 11 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.18106578 |
| 12 | Morphine addiction_Homo sapiens_hsa05032 | 2.14781542 |
| 13 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.14406096 |
| 14 | Allograft rejection_Homo sapiens_hsa05330 | 2.11782714 |
| 15 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.09419239 |
| 16 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 2.01440173 |
| 17 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.99965133 |
| 18 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.91680628 |
| 19 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.90754308 |
| 20 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.85624303 |
| 21 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.81601843 |
| 22 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.79429909 |
| 23 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.75066544 |
| 24 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.71486887 |
| 25 | GABAergic synapse_Homo sapiens_hsa04727 | 1.56910788 |
| 26 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.31954554 |
| 27 | Sulfur relay system_Homo sapiens_hsa04122 | 1.22971210 |
| 28 | Ribosome_Homo sapiens_hsa03010 | 1.19373642 |
| 29 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.18606086 |
| 30 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.16252624 |
| 31 | Homologous recombination_Homo sapiens_hsa03440 | 1.16082011 |
| 32 | Olfactory transduction_Homo sapiens_hsa04740 | 1.16022545 |
| 33 | Viral myocarditis_Homo sapiens_hsa05416 | 1.14811293 |
| 34 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.13535227 |
| 35 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.06567006 |
| 36 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.03166415 |
| 37 | Basal transcription factors_Homo sapiens_hsa03022 | 0.99654022 |
| 38 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.95730504 |
| 39 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.94172008 |
| 40 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.93857266 |
| 41 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.93011314 |
| 42 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.91705586 |
| 43 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.89377077 |
| 44 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.84493308 |
| 45 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.84369618 |
| 46 | Asthma_Homo sapiens_hsa05310 | 0.80907882 |
| 47 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.80823730 |
| 48 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.79898873 |
| 49 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.79557470 |
| 50 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.77939687 |
| 51 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.74960853 |
| 52 | Retinol metabolism_Homo sapiens_hsa00830 | 0.74052418 |
| 53 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.73139993 |
| 54 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.70510536 |
| 55 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.67896782 |
| 56 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.64380913 |
| 57 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.63327750 |
| 58 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.60342945 |
| 59 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.60094157 |
| 60 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.59346970 |
| 61 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.58306432 |
| 62 | ABC transporters_Homo sapiens_hsa02010 | 0.56413031 |
| 63 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.55594688 |
| 64 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.53431636 |
| 65 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.53027599 |
| 66 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.52819835 |
| 67 | Bile secretion_Homo sapiens_hsa04976 | 0.51216579 |
| 68 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.51037618 |
| 69 | Histidine metabolism_Homo sapiens_hsa00340 | 0.50441768 |
| 70 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.48255852 |
| 71 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.45404321 |
| 72 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.44248022 |
| 73 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.43911954 |
| 74 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.43490491 |
| 75 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.42083046 |
| 76 | Circadian entrainment_Homo sapiens_hsa04713 | 0.39203421 |
| 77 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.38825925 |
| 78 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.38744171 |
| 79 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.38736021 |
| 80 | Parkinsons disease_Homo sapiens_hsa05012 | 0.37392093 |
| 81 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.36274033 |
| 82 | Salivary secretion_Homo sapiens_hsa04970 | 0.32690323 |
| 83 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.31315930 |
| 84 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.30502217 |
| 85 | Metabolic pathways_Homo sapiens_hsa01100 | 0.29852144 |
| 86 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.28782015 |
| 87 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.27412078 |
| 88 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.25672272 |
| 89 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.23506711 |
| 90 | Huntingtons disease_Homo sapiens_hsa05016 | 0.22978082 |
| 91 | Measles_Homo sapiens_hsa05162 | 0.22668965 |
| 92 | Insulin secretion_Homo sapiens_hsa04911 | 0.22468947 |
| 93 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.22249829 |
| 94 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.22103741 |
| 95 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.21918950 |
| 96 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.20775155 |
| 97 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.18611224 |
| 98 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.16966235 |
| 99 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.15895998 |
| 100 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.15056345 |

